5AM Venture Management, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001799883
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2024 · 26 positions · Total reported value $446.63M · Top-10 concentration 68.5% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 43.8% · 0 new · 6 cut · 1 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -23.4% · vs SPY -25.5% · Prev Value $287.89M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -24.1% · vs SPY -26.3% · Latest Value $297.01M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2024 13F filing, 5AM Venture Management, LLC disclosed 26 equity positions with a combined reported value of $446.63M. The filing implies a focused portfolio: its ten largest positions account for 68.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2024 were ELVN ($67.47M), TRDA ($62.47M), DNTH ($37.26M). By sector, the heaviest allocations are Health Care 82.9%, Other 17.1%. Versus the prior quarter, allocation shifted toward Other (+4.9pp) and away from Health Care (-4.9pp).
Versus the prior quarter, 5AM Venture Management, LLC opened 0 new positions, trimmed 6 and fully exited 1, a turnover rate of 43.8% of positions. The portfolio's overlap with the prior quarter was 70% of names.
The largest new positions opened in Q1 2024 were PRAX ($20.75M), CNTA ($14.07M), SLN ($10.29M).
Of the 1 positions fully exited versus the prior quarter, the largest were IRON ($16.99M), MRTX ($11.31M), SPRB ($6.93M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2024)
- PRAX PRAXIS PRECISION MEDICINES I · $20.75M
- CNTA CENTESSA PHARMACEUTICALS PLC · $14.07M
- SLN SILENCE THERAPEUTICS PLC · $10.29M
- ADVM ADVERUM BIOTECHNOLOGIES INC · $7.66M
- QTTB Q32 BIO INC · $4.29M
Insider Transactions (Form 4)
Latest 5AM Venture Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
5AM Venture Management, LLC is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q3 2026 it reported 15 US equity positions with a combined value of $297.01M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: SAN FRANCISCO, CA, United States
- SEC registration: 801-120173 (status: Approved), registered 2021-01-19
- Regulatory AUM (Form ADV): $1.08B as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 12 private funds, of which 1 hedge funds
- Website: 5amventures.com
Portfolio Structure
- 15 positions · $297.01M reported value (Q3 2026)
- Top 10 holdings = 93.7% of reported value
- Largest position: ARTV (ARTIVA BIOTHERAPEUTICS INC) at 46.8%
- Average position size: $19.80M
Sector Tilt
- Health Care 98.8%
- Industrials 1.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 1 added, 6 reduced, 1 exited
- 8 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
3.84M | $67.47M | 15.11% | Reduce | |
| 2 |
|
4.41M | $62.47M | 13.99% | Hold | |
| 3 |
|
1.24M | $37.26M | 8.34% | Reduce | |
| 4 |
|
548.83K | $24.71M | 5.53% | Add | |
| 5 |
|
497.27K | $20.87M | 4.67% | Hold | |
| 6 |
|
340.00K | $20.75M | 4.64% | New | |
| 7 |
|
237.56K | $19.48M | 4.36% | Reduce | |
| 8 |
|
797.60K | $18.43M | 4.13% | Hold | |
| 9 |
|
319.97K | $17.50M | 3.92% | Reduce | |
| 10 |
|
665.55K | $16.98M | 3.80% | Hold | |
| 11 |
|
939.30K | $15.40M | 3.45% | Add | |
| 12 |
|
6.36M | $15.08M | 3.38% | Hold | |
| 13 |
|
282.31K | $14.18M | 3.17% | Reduce | |
| 14 |
|
1.25M | $14.07M | 3.15% | New | |
| 15 |
|
736.60K | $12.90M | 2.89% | Add | |
| 16 |
|
476.20K | $10.29M | 2.30% | New | |
| 17 |
|
357.73K | $8.06M | 1.80% | Hold | |
| 18 |
|
490.00K | $7.72M | 1.73% | Hold | |
| 19 |
|
541.67K | $7.66M | 1.72% | New | |
| 20 |
|
3.63M | $6.72M | 1.50% | Hold | |
| 21 |
|
572.66K | $6.10M | 1.37% | Add | |
| 22 |
|
1.20M | $6.03M | 1.35% | Hold | |
| 23 |
|
1.30M | $5.85M | 1.31% | Hold | |
| 24 |
|
790.44K | $5.31M | 1.19% | Hold | |
| 25 |
|
251.99K | $4.29M | 0.96% | New | |
| 26 |
|
1.13M | $1.04M | 0.23% | Hold | |
FAQ
What did 5AM Venture Management, LLC buy in 2024-Q1?
In its 2024-Q1 13F filing, 5AM Venture Management, LLC reported 26 equity positions worth $446.63M in aggregate; its largest disclosed positions were ELVN ($67.47M), TRDA ($62.47M), DNTH ($37.26M).
How large is 5AM Venture Management, LLC's portfolio?
5AM Venture Management, LLC reported $446.63M of long equity holdings across 26 positions as of 2024-Q1. Top-10 holdings account for 68.5% of reported value.
What is 5AM Venture Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.